Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
Immune cell trafficking from the brain maintains CNS immune tolerance.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Periventricular Demyelination and Axonal Pathology Is Associated with Subependymal Virus Spread in a Murine Model for Multiple Sclerosis.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Ximino
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Glial contributions to neural function and disease.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
ONO-4641 Met Primary Endpoint of Phase II Study in Multiple Sclerosis Patients

Pages